Our Mission

 

We strive to build strong relationships with our customers by providing high quality health care solutions. We offer the ArthriFon® family of medical devices at competitive prices in order to make it easy for our customers to pursue and maintain optimal health conditions.

 

Since the beginning of our company, our first and foremost mission has been to provide products that we could take pride in, and which would give comfort to those who needed relief, including ourselves and our friends, among whom we like to include our customers.

 

As part of our advocacy for awareness about the ArthriFon® family of health care products, our staff has been fully trained to answer any questions or concerns our customers may have. The best decisions are informed decisions.

 

Yury M. Podrazhansky Ph.D.

President , CEO and CTO of ECR Corp



 


  Yury M. Podrazhansky graduated from the Kharkov Institute of Radio Electronics with a Masters of Science in Electronic and Radio Frequency engineering (RF engineer). He earned his doctorate degree from the State Chemical Technology University, Ukraine

   He has been Vice President of Research and Development in various Georgia corporations and has been featured in various newspapers such as Forbes, The New York Times, and Atlanta Journal Constitution; has written 10 method patents; published a number of articles in different professional journals and presented papers at different meetings and conferences. He has been doing research in VibroAcoustic technology for more than 6 years.   His 10 US Patents was referenced 187 times untill now (avarage 3 references per one US Patent). You can look at www.US Patent and Trade Mark Office.gov

To see article about Dr. Yury Podrazhansky inventions in Forbes please click at: www.FORBES article 
 

Dr. Mikhail Lyubich,MD,

Vice President of ECR Corp.

Head of Medical Research
 

Certified by American Board of Internal Medicine

  Mikhail Lyubich earned his MD degree from Kalinin Medical Institute in 1981.

He completed his residency at St. Luke’s Hospital in Bethlehem, Pennsylvania, which is affiliated with the Temple University School of Medicine.

  Dr. Lyubich is board certified in internal medicine by the American Board of Internal Medicine and has his own private practice at Crawford Long Hospital of Emory University in Atlanta, GA.

  He has particular interest in VibroAcoustic medicine and men’s health.

Dr. Lyubich helped apply VibroAcoustic technology to medicine and co-authored with Dr. Podrazhansky two patents for VibroAcoustic therapy (pending approval).

Mikhail Lyubich, MD and Yury M. Podrazhansky, Ph.D wrote “Eliminate Joint Pain” book, which contains detailed explanations about vibroacoustic technology and Arthrifon® SMP.
 

Electrochemical Research Corporation (ECR Corp.), a Georgia- based company, has developed a novel method and device, which uses Vibroacoustic (Sound) therapy to treat joint pain.

Vibro Sound Therapy is widely spread in UK , Germany, Switzerland, Russia, and throughout the Far East for more than two decades.

While this technology has been known here in the US only as a music relaxing therapy, it has never been designed specifically for the treatment of joint pain.

Our company mission is advancement of this technology and making it widely available for joint pain sufferers in the USA and worldwide.

Dr. Podrazhansky, using his knowledge in Molecular Physics, ElectroChemistry and Electronics founded ECR Corp. in 2001, in a personal quest to find the “cure” to control his knee and hips pain caused by arthritis.

Dr. Podrazhansky, in collaboration with Mikhail Lyubich, MD searched and studied all available materials related to Vibroacoustic (Sound) therapy.

Simultaneously, they designed a therapeutic regimen specifically for the treatment of joint pain and with a team of scientists and physicians created a new, safe and effective electronic device called the ArthriFon®.(the name coming from “Arthri” referring to “arthritis” and “Fon” referring to sound). During the past two years, more than 900 of these devices have been sold in the USA and abroad.

ECR Corp. registered the ArthriFon®. with the FDA as a therapeutic Class I medical device in 2003. .

In April 2005, the SADMERC tested and assigned a HCPCS level II code A9270 to the ArthriFon® for Medicare recipients.
 

As always, we thank you for your patronage!

Electrochemical Research Corporation (ECR Corp.)

ArthriFon® SMP - your life without pain

Copyright © 2005, 2006, 2007and 2008 by Electrochemical Research Corporation

2831 Peterson Place, Norcross, GA 30071